Dr. Crawford on Ongoing Trials of Genetic Testing for Prostate Cancer

E. David Crawford, MD
Published Online: Wednesday, Apr 19, 2017



E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses ongoing trials regarding genetic testing for patients with prostate cancer.

There are trials that are beginning predicated on advanced disease but overall there is not much data available in this space, explains Crawford.

Developing more data and determining the impact that genetic testing can have on patients with prostate cancer is an exciting time for the field, states Crawford.
 


E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses ongoing trials regarding genetic testing for patients with prostate cancer.

There are trials that are beginning predicated on advanced disease but overall there is not much data available in this space, explains Crawford.

Developing more data and determining the impact that genetic testing can have on patients with prostate cancer is an exciting time for the field, states Crawford.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Genitourinary CancersJul 28, 20171.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
$emailPop$